Clarity Pharmaceuticals Adds Two Complete Responses to SECuRE Trial Data
· smallcaps.com.au
Clarity Pharma reports two new complete responses at 8GBq in SECuRE trial, boosting radiographic disease control to seven; PSA declines strong.
Clarity Pharmaceuticals (ASX: CU6) has reported two additional complete responses among participants receiving the 8 gigabecquerel (GBq) dose of 67Cu-SAR-bisPSM...